cysteine and Bladder Cancer

cysteine has been researched along with Bladder Cancer in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (16.67)	18.7374
1990's	3 (25.00)	18.2507
2000's	1 (8.33)	29.6817
2010's	6 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hua-Lei, L; Jing, C; Li, Z; Qian-Wei, X; Weng-Guang, L; You, W; Yu-Ping, Z	1
Chiong, E; Kang, ET; Lu, S; Mahendran, R; Neoh, KG; Xu, L; Zhang, Q	1
Itoh, K; Liu, T; Maruyama, A; Mimura, J; Ohyama, C; Okada, T; Sato, H; Ye, P	1
Bi, D; Ding, K; Ding, S; Li, J; Liu, S; Lu, J; Niu, Z; Sun, L; Wu, F; Zhang, H; Zhao, Z	1
Ding, S; Fujii, N; Kobayashi, T; Lv, J; Nishiyama, H; Nishizawa, K; Ogawa, O; Oishi, S	1
Bhattacharya, A; Geng, F; Li, Y; Munday, R; Zhang, Y	1
Amorós, A; Carrato, A; Hernández, S; Kogevinas, M; Lloreta, J; López-Knowles, E; Malats, N; Real, FX; Serra, C; Tardón, A	1
Hohorst, HJ; Voelcker, G; Wagner, T; Wientzek, C	1
Hohorst, HJ; Laber, P; Rockinger, H; Voelcker, G; Wientzek, C	1
Cherian, MG; Imura, N; Satoh, M; Shimizu, H	1
Cai, R; Fujishima, A; Hashimoto, K; Hosaka, M; Kawasaki, C; Kitamura, H; Kubota, Y; Sakai, H; Shuin, T	1
Benson, PJ; Gupta, V; Hu, X; Pinto, T; Singh, S; Xia, H; Zaren, HA	1

Reviews

1 review(s) available for cysteine and Bladder Cancer

Article	Year
MTHFR C677T and A1298C polymorphisms were associated with bladder cancer risk and disease progression: a meta-analysis. DNA and cell biology, 2013, Volume: 32, Issue:5 Topics: Alanine; Amino Acid Substitution; Carcinoma; Case-Control Studies; Cysteine; Disease Progression; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Risk Factors; Threonine; Urinary Bladder Neoplasms	2013

Article

Year

MTHFR C677T and A1298C polymorphisms were associated with bladder cancer risk and disease progression: a meta-analysis.

DNA and cell biology, 2013, Volume: 32, Issue:5

Topics: Alanine; Amino Acid Substitution; Carcinoma; Case-Control Studies; Cysteine; Disease Progression; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Risk Factors; Threonine; Urinary Bladder Neoplasms

2013

Other Studies

11 other study(ies) available for cysteine and Bladder Cancer

Article	Year
Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy. Langmuir : the ACS journal of surfaces and colloids, 2014, Jun-03, Volume: 30, Issue:21 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cysteine; Disulfides; Doxorubicin; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Nanoparticles; Protein Structure, Tertiary; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Sulfhydryl Compounds; Surface Properties; Swine; Urinary Bladder Neoplasms	2014
Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition. Molecular and cellular biology, 2014, Sep-15, Volume: 34, Issue:18 Topics: Activating Transcription Factor 4; Amino Acid Transport System y+; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cysteine; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glutathione; Glycine; HEK293 Cells; HeLa Cells; Humans; Leupeptins; NF-E2-Related Factor 2; Oligopeptides; Proteasome Endopeptidase Complex; Pyrazines; RNA, Small Interfering; Sulfasalazine; Urinary Bladder Neoplasms	2014
A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer. PloS one, 2015, Volume: 10, Issue:12 Topics: Animals; Apoptosis; Cell Line, Tumor; Cluster Analysis; Cysteine; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kinesins; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleoside Diphosphate Reductase; RNA Interference; Trityl Compounds; Tumor Burden; Tumor Suppressor Proteins; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays	2015
A potent chemotherapeutic strategy for bladder cancer: (S)-methoxy-trityl-L-cystein, a novel Eg5 inhibitor. The Journal of urology, 2010, Volume: 184, Issue:3 Topics: Animals; Cell Line, Tumor; Cysteine; Drug Screening Assays, Antitumor; Female; Humans; Kinesins; Mice; Mice, Inbred BALB C; Urinary Bladder Neoplasms	2010
The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer. Carcinogenesis, 2012, Volume: 33, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine; Down-Regulation; Female; Humans; Isothiocyanates; Neoplasm Invasiveness; Rats; Rats, Inbred F344; Thiocarbamates; Tubulin; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A	2012
Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Aug-01, Volume: 24, Issue:22 Topics: Adult; Aged; Aged, 80 and over; Alanine; Cysteine; Female; Glutamic Acid; Glycine; Humans; Leucine; Male; Middle Aged; Multivariate Analysis; Mutation; Phenylalanine; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Receptor, Fibroblast Growth Factor, Type 3; Sequence Analysis, DNA; Serine; Tyrosine; Urinary Bladder Neoplasms	2006
Pharmacokinetics of "activated" cyclophosphamide and therapeutic efficacies. Cancer, 1984, Sep-15, Volume: 54, Issue:6 Suppl Topics: Animals; Cyclophosphamide; Cysteine; Drug Administration Schedule; Female; Kinetics; Male; Mice; Urinary Bladder Neoplasms	1984
The influence of the protector thiol L-cystein on the toxic and therapeutic responses of stabilized "activated" cyclophosphamide (4-(S-ethanol)-sulfido-cyclophosphamide). Investigational new drugs, 1984, Volume: 2, Issue:2 Topics: Animals; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Cysteine; Female; Humans; Lethal Dose 50; Male; Mice; Mice, Nude; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Sarcoma, Yoshida; Structure-Activity Relationship; Transplantation, Heterologous; Urinary Bladder Neoplasms	1984
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer research, 1994, Oct-15, Volume: 54, Issue:20 Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibrosarcoma; Glycine; Humans; Male; Melphalan; Metallothionein; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Pargyline; Sulfates; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Zinc Compounds; Zinc Sulfate	1994
Photokilling of T-24 human bladder cancer cells with titanium dioxide. British journal of cancer, 1994, Volume: 70, Issue:6 Topics: Catalase; Cell Survival; Cysteine; Humans; In Vitro Techniques; Microscopy, Electron; Titanium; Tumor Cells, Cultured; Ultraviolet Rays; Urinary Bladder Neoplasms	1994
Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C. Cancer research, 1996, Aug-01, Volume: 56, Issue:15 Topics: Antineoplastic Agents, Alkylating; Biotransformation; Buthionine Sulfoximine; Cysteine; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Humans; Methionine Sulfoximine; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms	1996